Apr 29, 2021 8:00am EDT Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPARâ„¢ Opioid with Overdose Protection
Feb 18, 2021 7:30am EST Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer
Dec 31, 2020 8:00am EST Ensysce Biosciences, a California Based Biotech With a Mission to Solve the Opioid Crisis, Secures $60 Million Capital Commitment From Global Emerging Markets
Sep 28, 2020 8:00am EDT COVISTAT, a Subsidiary of Ensysce Biosciences Inc, a California Based Company With a Mission to Solve the Opioid Crisis, Is Commencing Phase 1 Study of Novel COVID-19 Treatment
Sep 08, 2020 8:00am EDT Ensysce Biosciences, a California Based Biotech With a Mission to Solve the Opioid Crisis, Announces Steven R. Martin to Join Board of Directors
Apr 15, 2020 8:00am EDT Ensysce, a California Based Biotech Company With a Mission to Solve the Opioid Crisis, Exploring a Treatment for COVID-19.
Sep 26, 2019 8:00am EDT Ensysce Biosciences Receives Multi-Year NIH HEAL Grant to Develop a Novel Opioid-Use-Disorder (OUD) Medication